Main
>
MEDICINE
>
HyperEosinophilic Syndrome
>
Treatment
>
MepolizuMAb (IL-5 Inhibitor)
>
Co.: UK. G. (Phase III)
>
Company
This data is not available for free
Company's products
This section has no products